CRISPR Therapeutics AG Quarterly Current Ratio in % from Q2 2017 to Q2 2024

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: CRISPR Therapeutics AG quarterly Current Ratio history and growth rate from Q2 2017 to Q2 2024.
CRISPR Therapeutics AG Current Ratio for the quarter ending June 30, 2024 was 1.67K %, a 22% increase year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q2 2024	1.67K	+301	+22%	Jun 30, 2024
Q1 2024	1.62K	+173	+11.9%	Mar 31, 2024
Q4 2023	1.49K	-124	-7.71%	Dec 31, 2023
Q3 2023	1.44K	-287	-16.6%	Sep 30, 2023
Q2 2023	1.37K	-699	-33.8%	Jun 30, 2023
Q1 2023	1.45K	-837	-36.6%	Mar 31, 2023
Q4 2022	1.61K	-740	-31.5%	Dec 31, 2022
Q3 2022	1.73K	-598	-25.7%	Sep 30, 2022
Q2 2022	2.07K	-23.2	-1.11%	Jun 30, 2022
Q1 2022	2.28K	+527	+30%	Mar 31, 2022
Q4 2021	2.35K	+729	+44.9%	Dec 31, 2021
Q3 2021	2.33K	+749	+47.5%	Sep 30, 2021
Q2 2021	2.09K	+761	+57.2%	Jun 30, 2021
Q1 2021	1.76K	+406	+30%	Mar 31, 2021
Q4 2020	1.62K	+333	+25.8%	Dec 31, 2020
Q3 2020	1.58K	+371	+30.8%	Sep 30, 2020
Q2 2020	1.33K	-214	-13.9%	Jun 30, 2020
Q1 2020	1.35K	-279	-17.1%	Mar 31, 2020
Q4 2019	1.29K	-480	-27.1%	Dec 31, 2019
Q3 2019	1.21K	-585	-32.7%	Sep 30, 2019
Q2 2019	1.54K	-453	-22.7%	Jun 30, 2019
Q1 2019	1.63K	-374	-18.7%	Mar 31, 2019
Q4 2018	1.77K	-56.6	-3.1%	Dec 31, 2018
Q3 2018	1.79K	+61.2	+3.54%	Sep 30, 2018
Q2 2018	2K	+1.15K	+135%	Jun 30, 2018
Q1 2018	2.01K			Mar 31, 2018
Q4 2017	1.83K			Dec 31, 2017
Q3 2017	1.73K			Sep 30, 2017
Q2 2017	850			Jun 30, 2017

* An asterisk sign (*) next to the value indicates that the value is likely invalid.